FR2375868A1 - Agent a base de substances extraites du sang de veaux deproteine pour l'amelioration de l'irrigation sanguine et de la cicatrisation des plaies - Google Patents

Agent a base de substances extraites du sang de veaux deproteine pour l'amelioration de l'irrigation sanguine et de la cicatrisation des plaies

Info

Publication number
FR2375868A1
FR2375868A1 FR7739646A FR7739646A FR2375868A1 FR 2375868 A1 FR2375868 A1 FR 2375868A1 FR 7739646 A FR7739646 A FR 7739646A FR 7739646 A FR7739646 A FR 7739646A FR 2375868 A1 FR2375868 A1 FR 2375868A1
Authority
FR
France
Prior art keywords
blood
wound healing
deproteined
calves
improvement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7739646A
Other languages
English (en)
Other versions
FR2375868B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
THERA GmbH
Original Assignee
THERA GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by THERA GmbH filed Critical THERA GmbH
Publication of FR2375868A1 publication Critical patent/FR2375868A1/fr
Application granted granted Critical
Publication of FR2375868B1 publication Critical patent/FR2375868B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

Agent pour l'amélioration de l'irrigation sanguine et de la cicatrisation des plaies. L'agent selon l'invention, contenant des substances extraites du sang de veau déprotéiné est caractérisé par le fait qu'il contient 0,001 à 2,5 mu g de kinine par milligramme de substance sèche d'extrait. Application à l'industrie pharmaceutique.
FR7739646A 1977-01-03 1977-12-29 Agent a base de substances extraites du sang de veaux deproteine pour l'amelioration de l'irrigation sanguine et de la cicatrisation des plaies Granted FR2375868A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2700043A DE2700043C2 (de) 1977-01-03 1977-01-03 Mittel zur Verbesserung der Durchblutung und Wundheilung

Publications (2)

Publication Number Publication Date
FR2375868A1 true FR2375868A1 (fr) 1978-07-28
FR2375868B1 FR2375868B1 (fr) 1982-06-11

Family

ID=5998057

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7739646A Granted FR2375868A1 (fr) 1977-01-03 1977-12-29 Agent a base de substances extraites du sang de veaux deproteine pour l'amelioration de l'irrigation sanguine et de la cicatrisation des plaies

Country Status (9)

Country Link
US (1) US4177261A (fr)
JP (1) JPS53104713A (fr)
AT (1) AT356262B (fr)
CH (1) CH637018A5 (fr)
DE (1) DE2700043C2 (fr)
FR (1) FR2375868A1 (fr)
GB (1) GB1562871A (fr)
NL (1) NL188681C (fr)
SE (1) SE443510B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0013962A1 (fr) * 1979-01-23 1980-08-06 THERA Gesellschaft für Patentverwertung mbH Solution d'infusion contenant des acides amino et des sels minéraux

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5468737A (en) * 1982-05-07 1995-11-21 Carrington Laboratories, Inc. Wound healing accelerated by systemic administration of polysaccharide from aloe
GR82188B (fr) * 1983-06-03 1984-12-13 Caola Kozmetikai
HU190723B (en) * 1983-06-03 1986-10-28 Caola Kozmetikai Cosmetical composition containing protein-trace element adducts and process for producing them
US5165938A (en) * 1984-11-29 1992-11-24 Regents Of The University Of Minnesota Wound healing agents derived from platelets
US4937230A (en) * 1985-01-24 1990-06-26 Procyte Corporation Method of healing wounds in horses
US5348943A (en) * 1985-02-08 1994-09-20 Procyte Corporation Cosmetic and skin treatment compositions
US5214032A (en) * 1985-02-08 1993-05-25 Procyte Corporation GHL-CU pharmaceutical compositions and compounds
US5120831A (en) * 1985-02-08 1992-06-09 Procyte Corporation Metal-peptide compositions
US5550183A (en) * 1985-02-08 1996-08-27 Procyte Corporation Metal-peptide compositions and methods for stimulating hair growth
US4810693A (en) * 1985-02-08 1989-03-07 Procyte Corporation Method for inducing biological coverings in wounds
US5177061A (en) * 1985-02-08 1993-01-05 Procyte Corporation Method for stimulating hair growth using GHL-Cu complexes
AT389640B (de) * 1985-10-16 1990-01-10 Chemie Holding Ag Verfahren zum gleichzeitigen trocknen und granulieren von extraktstoffen aus enteiweisstem kaelberblut
JP2604457B2 (ja) * 1987-05-11 1997-04-30 プロサイト コーポレイション 毛の成長の刺激方法
US5145838A (en) * 1989-08-30 1992-09-08 Procyte Corporation Methods and compositions for healing ulcers
US5023237A (en) * 1989-08-30 1991-06-11 Procyte Corporation Methods and compositions for healing ulcers
US5059588A (en) * 1989-10-13 1991-10-22 Procyte Corporation, Incorporated Methods and compositions for healing bone using gly his lys: copper
US5118665A (en) * 1990-02-09 1992-06-02 Procyte Corporation Anti-oxidative and anti-inflammatory metal:peptide complexes and uses thereof
US5164367A (en) * 1990-03-26 1992-11-17 Procyte Corporation Method of using copper(ii) containing compounds to accelerate wound healing
JPH05163158A (ja) * 1991-12-13 1993-06-29 Sanwa Kagaku Kenkyusho Co Ltd 人尿性キニノゲナーゼを有効成分とする皮膚潰瘍の予防及び治療剤
KR0163563B1 (ko) * 1994-03-23 1998-12-01 김종인 피부질환 치료용 의약조성물
US5538945A (en) * 1994-06-17 1996-07-23 Procyte Corporation Stimulation of hair growth by peptide copper complexes
ES2125580T3 (es) * 1995-02-13 1999-03-01 Cci Ag Valvula accionada por el fluido controlado.
US5733884A (en) * 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
US20020076782A1 (en) * 1996-07-05 2002-06-20 John P.N. Rosazza Purified nitric oxide synthase
US7745106B2 (en) * 1997-06-24 2010-06-29 Cascade Medical Enterprises, Llc Methods and devices for separating liquid components
US20080199513A1 (en) * 1997-06-24 2008-08-21 Cascade Medical Enterprises, Llc Systems and methods for preparing autologous fibrin glue
US6979307B2 (en) * 1997-06-24 2005-12-27 Cascade Medical Enterprises Llc Systems and methods for preparing autologous fibrin glue
MXPA00000009A (es) 1998-06-22 2005-09-08 Autologous Wound Therapy Inc Solicitud para patente de utilidad para curativo de heridas mejorado enriquecido con plaquetas.
RU2209074C2 (ru) * 2001-08-29 2003-07-27 Общество с ограниченной ответственностью "Олимп" Состав для лечения ожогов
RU2222317C2 (ru) * 2001-10-01 2004-01-27 Российский научный центр "Восстановительная травматология и ортопедия" им. акад. Г.А.Илизарова Средство для стимуляции эпителизации раны
EP1890820A4 (fr) * 2005-03-22 2012-04-11 Cascade Medical Entpr Llc Systemes et methodes de production de membranes
RU2303987C1 (ru) * 2006-06-27 2007-08-10 Ооо "Нпф Ренам" Способ получения препарата для лечения дефектов кожи
US20090197892A1 (en) * 2007-08-21 2009-08-06 Nawaz Ahmad Anhydrous compositions useful for attaining enhanced sexual wellness

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2357507A1 (de) * 1973-11-17 1975-05-28 Bayer Ag Mittel zur fertilitaetssteigerung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2912359A (en) * 1955-05-04 1959-11-10 Developments Inc Wound healing agent obtained from blood and method of preparation
JPS5220524B1 (fr) * 1968-11-02 1977-06-04

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2357507A1 (de) * 1973-11-17 1975-05-28 Bayer Ag Mittel zur fertilitaetssteigerung

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0013962A1 (fr) * 1979-01-23 1980-08-06 THERA Gesellschaft für Patentverwertung mbH Solution d'infusion contenant des acides amino et des sels minéraux

Also Published As

Publication number Publication date
NL188681B (nl) 1992-04-01
ATA4078A (de) 1979-09-15
JPS6324976B2 (fr) 1988-05-23
GB1562871A (en) 1980-03-19
SE443510B (sv) 1986-03-03
FR2375868B1 (fr) 1982-06-11
DE2700043A1 (de) 1978-07-06
AT356262B (de) 1980-04-25
JPS53104713A (en) 1978-09-12
US4177261A (en) 1979-12-04
NL7800014A (nl) 1978-07-05
DE2700043C2 (de) 1983-12-08
CH637018A5 (de) 1983-07-15
NL188681C (nl) 1992-09-01
SE7800021L (sv) 1978-07-04

Similar Documents

Publication Publication Date Title
FR2375868A1 (fr) Agent a base de substances extraites du sang de veaux deproteine pour l'amelioration de l'irrigation sanguine et de la cicatrisation des plaies
BE873973A (fr) Derives de metronidazole et compositions pharmaceutiques en contenant
BE875634A (fr) Compositions pharmaceutiques et leur utilisation pour le traitement prophylactique et therapeutique de l'hyperplasie de la prostate
NL194748B (nl) Osmotische doseringsvorm voor behandeling van cardiovasculaire ziekten.
FR2448347A1 (fr) Composition pharmaceutique comprenant une acyl-carnitine pour le traitement des maladies vasculaires peripheriques
DE69021214D1 (de) Orale zusammensetzung für die behandlung intestinaler entzündlicher krankheiten.
BE877393A (fr) Phenethanolamines et compositions pharmaceutiques en contenant
ATE109351T1 (de) Therapeutisches erzeugnis zur behandlung von beschwerden während der oder nach den wechseljahren.
FR2506158A1 (fr) Medicament a base d'une association d'un inhibiteur de l'aromatase et d'un anti-androgene, utilisable pour le traitement et la prevention de l'hyperplasie de la prostate
FR2636628B1 (fr) Derives du thiadiazole-1,3,4, leur procede d'obtention et compositions pharmaceutiques en contenant
FR2510889B1 (fr) Medicament contenant certains phosphates ribofurannosyl-3',5'-cycliques substitues en 6, 8 pour le traitement de maladies proliferatives de la peau
FR2368958A1 (fr) Substances isolees de gonaderma lucidum (fr.) karst et leur application en therapeutique
FR2548023B1 (fr) Medicament veterinaire et solution de bain de pieds pour le traitement du pietin des ovins
FR2439194A1 (fr) Derives de la dibenzothiepine, leur procede de preparation et leur application therapeutique
FR2634103B1 (fr) Procede et produit permettant l'elimination des insectes nuisibles et accelerant le developpement des plantes traitees
PT77751B (fr) Procede de preparation de derives benzylideniques soufres et de compositions pharmaceutiques le contenant
FR2310769A1 (fr) Medicament pour le traitement de l'alopecia seborrhoeica
BE854137A (fr) Composition pharmaceutiques de traitement de l'acne
BE847308A (fr) Appareil pour le traitement en continu des colonnes de vide-ordures, des gaines d'aeration et des descentes de lignes
PT70005A (fr) Procede de preparation de nouveaux derives de 6-methoxy-2-acetylnaphtalene oxime et des compositions pharmaceutiquesles contenant
FR2427331A2 (fr) Derives de l'hydantoine et medicaments contenant ces substances
PT75767B (fr) Procede de preparation de derives de p-acylaminophenol a effet therapeutique et de compositions pharmaceutiques les contenant
BE856006A (fr) Nouveaux medicaments pour le traitement des surcharges lipidiques et de la cellulite
FR2447377A1 (fr) 25-hydroxycholecalciferol-26,23-lactone et composition pharmaceutique renfermant ce produit
FR1287716A (fr) Procédé de préparation d'un produit sec épandable, contenant une substance biologique active

Legal Events

Date Code Title Description
TP Transmission of property